Marvin Samuel Tolentino Pineda / Istoc Vitty Images
- ROCHE (OTCQX: RHHBY) announced that the American FDA had approved ARRAVIMO 100 mg / ml for the treatment of diabetic retinopathy.
- Approval allows us the retina specialists to offer ARAVIMO to DR patients who have already responded to at least two anti-VEGF injections.
